Table 1 Parameters of the screening model.
Model component | Parameter | Baseline estimate | Mininum estimate | Maximum estimate | Reference |
---|---|---|---|---|---|
Tumour induction due to radiation risk | Dose (mSv) | 3 | 1 | 5 | |
The lifetime probability of tumour induction | 0.51 | 0.28 | 0.83 | ||
Preclinical tumour growth | Mean preclinical period (years) | ||||
<50 years | 1.9 | 0.63 | 3.17 | Peer et al (1996); Tilanus-Linthorst et al (2007); Kriege et al (2006) | |
50–70 years | 3.7 | 1.23 | 6.17 | ||
>70 years | 4.5 | 1.50 | 7.50 | ||
s.d. (years) | |||||
<50 years | 0.63 | 0.21 | 1.05 | (Peer et al, 1996; Tilanus-Linthorst et al, 2007; Kriege et al, 2006) | |
50–70 years | 0.51 | 0.17 | 0.85 | ||
>70 years | 1.06 | 0.35 | 1.77 | ||
Tumour-doubling times (days) | |||||
<50 years | 80 | 27 | 133 | Peer et al (1996); Tilanus-Linthorst et al (2007); Kriege et al (2006)) | |
50–70 years | 157 | 52 | 262 | ||
>70 years | 188 | 63 | 313 | ||
Risk of developing breast during life | BRCA1 probability function | ||||
Lifetime risk at age 70 years | 0.80 | 0.71 | 0.84 | ||
Mean age (years) | 53.9 | 43.9 | 63.9 | ||
s.d. (years) | 16.5 | 5.5 | 28 | ||
BRCA2 probability function | |||||
Lifetime risk at age 70 years | 0.76 | 0.69 | 0.76a | ||
Mean age (years) | 58.5 | 48.5 | 68.5 | ||
s.d. (years) | 13.8 | 4.6 | 23 | ||
Sensitivity | Sensitivity of mammography at age <40 years | 0.333 | 0.279 | 0.397 | |
Sensitivity of mammography at age 40–49 years | 0.389 | 0.326 | 0.464 | ||
Sensitivity of mammography at age 50–54 | 0.556 | 0.466 | 0.663 | ||
Sensitivity of mammography at age 55–59 years | 0.697 | 0.584 | 0.832 | ||
Sensitivity of mammography at age ⩾60 years | 0.838 | 0.702 | 1 | ||
Sensitivity of MRI for all age groups | 0.770 | 0.593 | 1 | ||
Specificity | Specificity of mammography at age <40 years | 0.961 | 0.924 | 1 | |
Specificity of mammography at age ⩾40 years | 0.946 | 0.909 | 0.984 | ||
Specificity of MRI for all age groups | 0.863 | 0.745 | 1 | ||
Death rate | Average life expectancy population (years) | 79 | — | — | |
5-year survival rate breast cancer patients | |||||
Tumour diameter <20 mm | 0.98 | — | — | ||
Tumour diameter 20–50 mm | 0.86 | — | — | ||
Tumour diameter >50 mm | 0.62 | — | — |